Abstract
Introduction
Cancer and cancer treatments are associated with diabetes mellitus in some patients. The purpose of this review is to look at the association and potential impact of diabetes mellitus on the health profiles of a large cohort of cancer survivors.
Materials and methods
This is a descriptive, cross-sectional study of long-term cancer survivors who reported that they have diabetes. Of 8,559 respondents to a mailed survey, 696 (8.1%) reported diabetes mellitus (DM). We analyzed the responses to discern the potential impact of demographics, cancer type, or disease treatments on glycemia as well as the potential impact of DM on socioeconomic parameters (education, family and work).
Results
Survivors of gynecological cancer, chronic leukemia, or gastrointestinal cancer reported DM most frequently, although no statistical correlations could be demonstrated for DM and specific cancer types. The frequency of DM was higher among survivors than in the general U.S. population. Cancer survivors with DM were more likely to report that cancer affected their overall health (42.3 vs. 34.3%) and ability to work. They also reported more health problems.
Conclusions
Diabetes mellitus affects a minority of long-term cancer survivors and may have an impact on their physiologic and psychosocial well-being.
Implications for Cancer Survivors
Systematic assessment for DM is suggested for all cancer survivors because DM appears to be an important co-morbidity for this growing segment of our population.
Similar content being viewed by others
References
American Cancer Society. Annual Report to the Nation on the Status of Cancer, 1975–2001 with a Special Feature Regarding Survival. 2004, Atlanta, Georgia, American Cancer Society. Cancer, 101(1), 3–27.
Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2005. 2005, Atlanta GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
Comi, R. J. (2004). Drug-induced diabetes mellitus. In D. LeRoith,S. I. Taylor, & J. M. Olefsky (Eds.), Diabetes mellitus (pp. 879–886). Philadelphia: Lippincott Williams & Wilkins.
Demark-Wahnefried, W., Aziz, N. M., Rowland, J. H., & Pinto, B. M. (2005). Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. Journal of Clinical Oncolology, 23(24), 5814–5830, Aug 20.
Department of Health and Human Services. Vital and health statistics series 10, number 222. National health interview survey. 2002, Hyattsville, MD. US Department of Health and Human Services 2002.
Garman, K. S., et al. (2003). Function in elderly cancer survivors depends on comorbidites. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 12, M11119–M11124, Dec, 58.
Herman, D. R., Ganz, P. A., Petersen, L., & Greendale, G. A. (2005). Obesity and cardiovascular risk factors in younger breast cancer survivors: The Cancer and Menopause Study (CAMS). Breast Cancer Research and Treatment, 93(1), 13–23, Sept.
Hewitt, M., et al. (2006). From cancer patient to cancer survivor: Loss in transition. Washington DC: National Academies.
Kauppila, M., Koskinen, P., Irjala, K., Remes, K., & Viikari, J. (1998). Long-term effects of allogeneic bone marrow transplantation BMT on pituitary, gonad, thyroid, and adrenal function in adults. Bone Marrow Transplant, 22, 331–337.
Ko, C. Y., Maggard, M., & Livingston, E. H. (2003). Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: a nationwide, population-based assessment. Journal of Surgical Research, 114(1), 1–5, Sep.
Krechler, T., Novotny, J., Zeman, M., Krska, Z., Svestka, T., Svab, J., et al. (2004). Pancreatic carcinoma and diabetes mellitus. Cas Lek Ces, 143(2), 97–100.
Meinardi, M. T., Gietema, A., van der Graaf, W. T. A., van Veldhuisen, D. J., Runne, M. A., Sluiter, W. J., et al. (2000). Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol, 10, 1725–1732.
Nuver, J., Smit, A. J., Postma, A., Sleijfer, D. T., & Gietema, J. A. (2002). The metabolic syndrome in long-term cancer survivors, and important target for secondary preventive measures. Cancer Treatment Reports, 38, 195–214.
Pandit, M. K., Burke, J., Gustafson, A. B., Minocha, A., & Peiris, A. N. (1993). Drug-induced disorders of glucose intolerance. Ann Intern Med, 118(7), 529–539, Apr 1.
Peddi, V. R., Whiting, J., Weiskittel, P. D., & Alexander, J. W. (1998). Characteristics of long-term renal transplant survivors. American Journal of Kidney Diseases, 32(1), 101–106, Jul.
Pinto, B. M. & Trunzo, J. J. (2005). Health behaviors during and after a cancer diagnosis. Cancer, 104(11 Suppl), 2614–2623, Dec 1.
Schultz, P. N., Stava, C., & Vassilopoulou-Sellin, R. (2003). Health profiles and quality of life of 518 survivors of thyroid cancer. Head Neck, 25(5), 349–356, May.
Schultz, P. N., Beck, M. L., Stava, C., & Vassilopoulou-Sellin, R. (2003). Health profiles in 5836 long-term cancer survivors. International Journal of Cancer, 104(4), 488–495.
Schultz, P. N., Stava, C., Beck, M. L., & Vassilopoulou-Sellin, R. (2004). Ethnic/racial influences on the physiologic health of cancer survivors: Focus on long-term survivors of cervical carcinoma. Cancer, 1, 156–164, Jan.
Seo, P. H., Pieper, C. F., Cohen, H. J. (2004). Effects of cancer history and comorbid conditions on mortality and healthcare use among older cancer survivors. Cancer, 101(10), 2276–2284, Nov 15.
Stava, C., Beck, M., & Vassilopoulou-Sellin, R. (2005). Cataracts among cancer survivors. American Journal of Clinical Oncology, 28(6), 603–608, Dec.
Stava, C., Beck, M., Schultz, P. N., & Vassilopoulou-Sellin R. (2005). Hearing loss among cancer survivors. Oncology Reports, 13(6), 1193–1199, Jun.
Stava, C., Weiss, L. T., & Vassilopoulou-Sellin R. (2006). Health profiles of 814 very long-term breast cancer survivors. Clin Breast Cancer, 7(3), 228–236, Aug.
Stava, C., Beck, M., Weiss, L. T., Lopez, A., & Vassilopoulou-Sellin R. (2006). Health profiles of 996 melanoma survivors: The MD Anderson experience. BMC Cancer, 6, 95. Apr 18
Stava, C. J., Lopez A, & Vassilopoulou-Sellin R. (2006). Health profiles of younger and older breast cancer survivors. Cancer, 107(8), 1752–1759. Oct 15
Taskinen, M., Saarinen-Pihkala, U. M., Hovi, L., & Lipsanen-Nyman, M. (2000). Impaired glucose tolerance and dyslipidaemia as late effects after bone marrow transplantation in childhood. Lancet, 356, 993–997.
Wang F., Herrington, M., Larsson, J., & Permert, J. (2003). The relationship between diabetes and pancreatic cancer. Molecular Cancer, 2, 4, Jan 6.
Zhang, J., Shen, K., & Lang J. (2002). Study on chemotherapy-induced disorders of glucose metabolism in patients with malignant ovarian tumor. Zhonghua Fu Chan Ke Za Zhi, 37(8), 481–483, Aug.
Acknowledgement
We thank all the patients who responded to the survey, their healthcare teams who provided excellent care, Sarah Taylor for contribution to the mailed survey, and Annette Allett for manuscript preparation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stava, C.J., Beck, M.L., Feng, L. et al. Diabetes mellitus among cancer survivors. J Cancer Surviv 1, 108–115 (2007). https://doi.org/10.1007/s11764-007-0016-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-007-0016-z